Dalidnetug
Dalidnetug is a humanized monoclonal antibody targeting human amyloid-beta precursor protein (APP) . Dalidnetug specifically binds to APP to reduce the production of amyloid-beta (Aβ), thus exerting the activity of clearing amyloid-beta. Dalidnetug is promising for research of Alzheimer's disease[1].
Product Specifications
CAS Number
[2991369-43-6]
UNSPSC
12352203
Hazard Statement
H302, H315, H319, H335
Target
Amyloid-β
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Purity
96.686
Smiles
[Dalidnetug]
Molecular Weight
(146.524 kDa)
Precautions
H302, H315, H319, H335
References & Citations
[1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7069817 Inquire
Recombinant Bacillus subtilis Uncharacterized membrane protein yoaS (yoaS), partial
Ask
View Details 
